Convatec Group PLC (LON:CTEC)
London · Delayed Price · Currency is GBP · Price in GBX 215.40
-3.00 (-1.37%)
Mar 31, 2026, 4:47 PM GMT
Convatec Group Market Cap
Convatec Group has a market cap or net worth of 4.21 billion as of March 31, 2026. Its market cap has decreased by -19.93% in one year.
Market Cap
4.21B
Enterprise Value
5.29B
Revenue
1.81B
Ranking
n/a
PE Ratio
33.71
Stock Price
215.40
Market Cap Chart
Since October 26, 2016, Convatec Group's market cap has decreased from 4.39B to 4.21B, a decrease of -4.12%. That is a compound annual growth rate of -0.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 4.21B | -11.20% |
| Dec 31, 2025 | 4.74B | 4.77% |
| Dec 31, 2024 | 4.53B | -9.11% |
| Dec 29, 2023 | 4.98B | 4.77% |
| Dec 30, 2022 | 4.75B | 22.28% |
| Dec 31, 2021 | 3.89B | -2.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 221.82B |
| GSK plc | 81.92B |
| Haleon | 32.76B |
| Smith & Nephew | 10.14B |
| Hikma Pharmaceuticals | 2.70B |
| HUTCHMED (China) | 1.69B |
| Genus | 1.63B |
| Oxford Nanopore Technologies | 1.10B |